Navigation Links
John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
Date:2/16/2011

HACKENSACK, N.J. (February 16, 2011) The Division of Breast Oncology at the John Theurer Cancer Center at Hackensack University Medical Center will host the Eighth Annual Northern New Jersey Breast Cancer Conference on Friday, February 18 from 7:00 am 3:30 pm. This free continuing medical education (CME) event will present highlights from the 34th Annual San Antonio Breast Cancer Symposium, an international scientific symposium for breast cancer basic scientists and clinicians, to tri-state area oncologists, hematologists, other physicians and healthcare professionals.

"Each year, an international gathering of leading breast oncologists attend the San Antonio Breast Cancer Symposium to discuss the latest research and treatment methods in breast cancer," said Stanley Waintraub, M.D., F.A.C.P., Co-Chief of Breast Oncology at the John Theurer Cancer Center. "The Eighth Annual Northern New Jersey Breast Cancer Conference provides area physicians and healthcare professionals an opportunity to learn the latest breast cancer research findings so they can apply these learnings to the clinic."

The conference will take place in Hackensack University Medical Center's Hekemian Conference Center and is worth a maximum of 6.0 AMA PRA Category 1 Credits. Topics to be covered include breast cancer screening policy, conflicting viewpoints in newer treatments for advanced breast cancer, radiation therapy in lymph node involvement, neoadjuvant therapy, clinical trials, genomic & molecular profiling, emerging targeted therapies, and use of hormonal therapies before and after diagnosis.

"Education is paramount in advancing research and providing patients with cutting-edge care," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services at Hackensack University Medical Center. "Collaborating with leading experts from outside institutions is key in delivering the best education and updates to our staff and the local healthcare community."

Featured Speakers at this conference include:

  • Stanley E. Waintraub, M.D., F.A.C.P., Co-Chief of Breast Oncology, John Theurer Cancer Center
  • Freya R. Schnabel, M.D., Professor of Surgery, NYU School of Medicine
  • Mary Elizabeth Cianfrocca, D.O., Feinberg School of Medicine, Northwestern University
  • Lawrence J. Solin, M.D., F.A.C.R., Chairman of Radiation Oncology, Albert Einstein Medical Center
  • Howard A. Burris, M.D., Director of Drug Development, Sarah Cannon Research Institute
  • Edith A. Perez, M.D., Director of Breast Program and Professor of Medicine, Mayo Clinic
  • Adam Brufsky, M.D., Ph.D., Associate Chief of the Division of Hematology/Oncology and Professor of Medicine, University of Pittsburgh
  • Brian Leyland-Jones, M.D., Director, Emory Winship Cancer Institute, Emory University
  • Harold A. Harvey, M.D., Director, Professor of Medicine and Director, Hematology/Oncology Fellowship Program, Milton S. Hershey Medical Center

This CME conference is free and directed primarily for medical oncologists and hematologists, as well as nurses and other healthcare professionals in the oncology field who are interested in the treatment of breast cancer. To register in advance, please contact Bonnie LoGiudice at 201-996-4891 or blogiudice@humed.com.


'/>"/>

Contact: Amy Leahing
amy.leahing@widmeyer.com
646-213-7245
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. Oncology basic research director at John Theurer Cancer Center continues transplantation research
2. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
3. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
4. John Theurer Cancer Center to present innovative research at 2 surgical meetings
5. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
6. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
7. The John Theurer Cancer Center recognizes medical physics team for safety track record
8. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
9. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
10. John Theurer Cancer Center offers breakthrough radiation measurement technology
11. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: